SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-242162
Filing Date
2019-09-10
Accepted
2019-09-10 17:19:42
Documents
20
Period of Report
2019-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d757377d8k.htm   iXBRL 8-K 56396
2 EX-4.1 d757377dex41.htm EX-4.1 578680
3 EX-10.1 d757377dex101.htm EX-10.1 225119
7 GRAPHIC g757377dsp50.jpg GRAPHIC 2455
8 GRAPHIC g757377dsp51.jpg GRAPHIC 2820
9 GRAPHIC g757377dsp53.jpg GRAPHIC 2832
10 GRAPHIC g757377dsp54.jpg GRAPHIC 2879
11 GRAPHIC g757377dsp55.jpg GRAPHIC 2419
12 GRAPHIC g757377dsp56.jpg GRAPHIC 3906
  Complete submission text file 0001193125-19-242162.txt   1180637

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aeri-20190904.xsd EX-101.SCH 3078
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20190904_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20190904_pre.xml EX-101.PRE 11413
18 EXTRACTED XBRL INSTANCE DOCUMENT d757377d8k_htm.xml XML 3420
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 191086210
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1